In a pharmacokinetic substudy of the randomized ASSET trial , @ de novo kidney transplant patients receiving very low ( @-@ ng/mL ) or low ( @-@ ng/mL ) tacrolimus exposure after month @ , both with everolimus and steroids , provided area under the curve ( AUC ) concentration profiles at day @ and months @ , @ , and @ .